SooHwan Kim, Taehwan Oh, Siyeon Yang, Hyejean Cho, Chanhee Chae
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire 2021 JanThe objective of this study was to evaluate the efficacy of a new Mycoplasma hyopneumoniae bacterin against a Korean M. hyopneumoniae challenge under experimental conditions. Fifteen pigs were allocated randomly into 3 groups (5 pigs per group) that were designated in 1 of 3 ways: vaccinated-challenged, unvaccinated-challenged, or unvaccinated-unchallenged. The pigs in the vaccinated-challenged group were immunized with an M. hyopneumoniae whole-cell bacterin at a 1.0 mL dose-level at 21 d old. At 42 d old (0 d post-challenge), the pigs in the vaccinated-challenged and unvaccinated-challenged groups were inoculated intranasally with a strain of Korean M. hyopneumoniae. Vaccinated-challenged pigs elicited a strong cell-mediated immunity as measured by M. hyopneumoniae-specific interferon-γ secreting cells when compared with unvaccinated-challenged pigs. Vaccination of pigs with this new M. hyopneumoniae bacterin reduced nasal shedding and lung lesions. The evaluated vaccine was therefore considered effective in controlling M. hyopneumoniae infection. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.
SooHwan Kim, Taehwan Oh, Siyeon Yang, Hyejean Cho, Chanhee Chae. Experimental evaluation of Mycoplasma hyopneumoniae bacterin against a Korean M. hyopneumoniae challenge. Canadian journal of veterinary research = Revue canadienne de recherche veterinaire. 2021 Jan;85(1):77-81
PMID: 33390658
View Full Text